Aurobindo Pharma Q4 | Profit falls 7%, revenue from operations slips 2.5% YoY – Moneycontrol.com

Revenue from operations fell 2.5 percent YoY and 5.7 percent QoQ to Rs 6,001.5 crore in the March quarter. Excluding sales from divested Natrol, the revenue from operations increased by 2.1 percent. Read More